IDEX Corp (IEX) Keeps Momentum in Q2 2026: Record Orders, Doubling Down on Growth Outlook

Quarter in focus: solid top-line, disciplined margins, and a brighter guidance path

IDEX Corporation, traded on the NYSE under the ticker IEX, reported its second-quarter results for the three months ended June 30, 2026, on the back of a robust sales base and strong order intake. The company delivered a broad-based revenue improvement with a reported sales figure of $921 million, up 6% year over year and up 5% on an organic basis. In the earnings line, GAAP diluted EPS came in at $1.93, up 11% from a year ago, while adjusted diluted EPS rose 12% to $2.32. These numbers reflect a business that is growing where it matters, and the math is adding up even as the company keeps an eye on the profit ladder.

Beyond the headline numbers, the quarter reinforced a demand backdrop that management describes as resilient across its advantaged markets. The company announced record orders of over $1 billion for the quarter, signaling not just a momentary push but a sustained level of activity that could translate into continued backlog strength in the near term.

Highlights and strategic actions

• Sales and orders: Revenue of $921 million (+6% reported; +5% organic) and >$1 billion in quarterly orders.
• Profitability: GAAP EPS of $1.93; adjusted EPS of $2.32, with year-over-year gains of 11% and 12%, respectively.
• Capital allocation: Returned capital to shareholders via $77 million of share repurchases and $54 million in dividends.
• Guidance: Reaffirmed and “raised” full-year expectations by widening ranges for organic growth and adjusted EPS, signaling confidence in continued operating momentum.

Management highlighted ongoing progress on strategic initiatives and cost discipline, including the 8020 program aimed at strengthening growth and margin expansion across the portfolio. The combination of robust demand and ongoing efficiency actions helps explain the improved outlook and the willingness to lift guidance ranges.

Outlook: a brighter 2026 trajectory

The company updated its full-year organic growth trajectory to a range of 5% to 6%, up from a prior range of 3% to 4%. This indicates management’s confidence in sustaining demand and expanding market share through the back half of the year. While the press release emphasizes organic growth, investors will also watch how these dynamics translate into margin expansion and free cash flow, which historically support more aggressive capital return strategies and potential opportunities for strategic investments.

On the profitability front, IDEX signaled it will maintain a constructive stance toward EPS growth and capital discipline, with guidance for adjusted metrics raised alongside the revenue outlook. In practical terms, that means the market should expect ongoing coverage of the company’s earnings trajectory against the EPS consensus and the revenue forecast embedded in its guidance. If the current trend persists, the stock could trade with a bias toward constructive earnings revisions rather than mere revenue expansion.

What the results imply for IDEX and its peers

The quarter’s strength—record quarterly orders and a double-digit uptick in both GAAP and adjusted EPS—suggests that IDEX’s end markets are proving more durable than some cyclically sensitive segments. The emphasis on 8020 initiatives hints at a structural push to improve operating leverage without sacrificing growth investments, a balance that often distinguishes high-quality industrials in late-cycle environments.

For sector peers, several implications emerge:

• Robust order rates and disciplined cost management can create a favorable comparison for other diversified manufacturers with similar exposure to durable markets.
• Guidance that raises both organic growth and EPS targets may recalibrate investor expectations for mid-cap industrials, particularly those with strong aftermarket channels and defensible end-markets.
• Valuation sensitivity could tilt toward companies that demonstrate backlog depth alongside clear capital allocation discipline, as that combination strengthens visibility into revenue visibility and margin resilience.

Of course, the usual caveats about macro headwinds, supply-chain constraints, and inflation loops remain. Yet IDEX’s execution—mixing top-line momentum with margin-friendly efficiency programs—offers a blueprint for peers aiming to move beyond headline growth into durable earnings power.

Leadership perspective

“We are very pleased to see continued results momentum as our IDEX teams drove another quarter of strong sales and earnings growth. Orders of over $1 billion in the quarter were a record as we continue to see elevated demand across the advantaged markets where we’ve focused our investments and capabilities,”

— Eric D. Ashleman, Chief Executive Officer and President

“Our teams executed exceptionally well, as flow-through on strong volume drove earnings above our expectations, demonstrating the benefits of the work already completed to strengthen the quality of our businesses. We continue to advance 8020 initiatives to both fuel higher growth and unlock further margin expansion opportunities across IDEX.”

— quote from management

Bottom line and takeaways

IDEX’s Q2 2026 results underscore a company that is not merely riding a cycle but actively shaping its future through disciplined cost actions and a growth-focused strategy. The combination of rising EPS, solid cash generation, and an elevated revenue forecast sets a constructive tone for the balance of 2026. For investors, the question becomes less about whether the quarter was strong and more about whether the pace can be sustained as the company converts order intake into tangible, recurring profitability—the kind that supports durable revenue forecast accuracy and a credible path to continued EPS growth.

In the near term, IEX shares will likely be evaluated on the consistency of the organic growth trajectory and any incremental detail behind the updated guidance ranges. If the company can maintain this cadence, peers with similar market positions may find themselves pressured to demonstrate the same combination of organic acceleration and margin discipline that IDEX is signaling today.